BioAtla Inc. share price logo

BioAtla Inc.

NASDAQ: BCAB

Small Cap

$3.68

+0.13

(+3.66%)

as on

BioAtla Inc. Stock Performance

as on June 27, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $3.52
    $3.80
    downward going graph

    4.35%

    Downside

    3.26%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.12
    $71.50
    downward going graph

    15.22%

    Downside

    1842.93%

    Upside

    downward going graph

BioAtla Inc. share price movements today

Previous Close
$3.55
Open
$3.52
Volume
363.6K
Day's Low - High
$3.52 - $3.80
52 Week Low - High
$3.12 - $71.50

BioAtla Inc. Historical Returns

1 Month Return
-9.21 %
3 Month Return
-58.24 %
1 Year Return
-81.07 %
3 Year Return
-97.76 %
5 Year Return
-99.83 %

BioAtla Inc. Stock Fundamentals & Key Indicators

Check BioAtla Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.3M

EPS (TTM)

-1.3767

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-50.1M

Revenue (TTM)

2.0M

Profit Margin

0.00%

Return On Equity TTM

-813.88%

BioAtla Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of BioAtla Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BioAtla Inc. image
BioAtla Inc.
BUY$6.3M-99.83%NA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$39.3B67.15%74.0712.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$120.6B147.08%28.1735.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$65.4B12.64%15.2229.65%0.58%

Stock Returns calculator for BioAtla Inc. Stock including INR - Dollar returns

The BioAtla Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

BioAtla Inc. investment value today

Current value as on today

₹21,596

Returns

-₹78,404

(-78.4%)

Returns from BioAtla Inc. Stock

-₹80,373 (-80.37%)

Dollar Impact

₹1,970 (+1.97%)

Analyst Recommendation on BioAtla Inc. Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for BioAtla Inc.. Average target price of $10

BioAtla Inc. Share Price Target

Get share price movements and forecasts by analysts on BioAtla Inc..

What analysts predicted

63.2%UPSIDE

Target Price

$10

Current Price

$3.68

Analyzed by

11 Analysts

Target

$10.00

BioAtla Inc. target price $10, a slight upside of 63.2% compared to current price of $3.68. According to 11 analysts rating.

Indian Investors' Interest in BioAtla Inc. Stock

Search interest for BioAtla Inc. Stock has decreased by -14% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-14% versus previous 30 day period

BioAtla Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
1
-
-
11
-
-
-
-
2
-
Gross Profit
0
0
0
10
-11
0
0
0
2
0
Operating Income
-28
-24
-21
-11
-16
-17
-18
-13
-9
-8
EBITDA
-26
-22
-20
-10
-14
-15
-18
-15
-7
-6
Interest Expense
1
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-26
-23
-21
-10
-14
-15
-18
-15
-9
-6
Income Tax Expense
4
0
-
-
-
-
-
-
-
-
Net Income
-26
-23
-21
-10
-14
-15
-18
-15
-9
-6
Net Profit Margin
-1578.25%
0.00%
0.00%
-96.24%
0.00%
0.00%
0.00%
0.00%
-489.20%
0.00%

BioAtla Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
10
5
0
0
-
-
11
2
Gross Profit
-15
-20
-19
-58
-1
-1
10
2
Operating Income
-28
-28
-30
-96
-108
-129
-73
-59
EBITDA
-27
-27
-33
-94
-105
-122
-68
-59
Interest Expense
0
1
1
0
1
-
-
-
Depreciation
0
0
1
1
1
1
0
0
Income Before Tax
-28
-29
-35
-95
-106
-123
-69
-59
Income Tax Expense
0
1
1
0
-1
-
-
-
Net Income
-28
-29
-35
-95
-105
-123
-69
-59
Net Profit Margin
-272.69%
-572.96%
-8357.34%
-38160.80%
0.00%
0.00%
-634.33%
-2980.35%

BioAtla Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-23
-21
-10
-14
-15
-18
-15
-9
-6
Operating Cash Flow
-30
-19
-5
-16
-16
-14
-9
-7
-5
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
0
0
0
9
0
0
0
6
0
Change in Cash
-30
-18
-5
-7
-16
-14
-9
-1
-5

BioAtla Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-29
-35
-95
-106
-123
-69
-59
Operating Cash Flow
-9
-36
-62
-90
-104
-71
-48
Investing Cash Flow
-1
0
0
0
0
-
-
Financing Cash Flow
3
271
69
61
0
9
6
Change in Cash
-7
234
6
-29
-104
-62
-41

Global Institutional Holdings in BioAtla Inc.

Funds
Holdings
Millennium Management LLC
3.33%
Northern Trust Corp
0.12%
Commonwealth Equity Services Inc
0.03%
Stonepine Capital Management Llc
0.08%
Two Sigma Investments LLC
0.1%
See all

Insights on BioAtla Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, BioAtla, Inc. Common Stock has experienced a drawdown of -97.5%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 87.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 21.5% return, outperforming this stock by 102.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, BCAB stock has moved down by -52.0%

About BioAtla Inc.

BioAtla, Inc., a clinical-stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead clinical stage product candidates include mecbotamab vedotin (BA3011), a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for treating undifferentiated pleomorphic sarcoma and non-small cell lung cancer (NSCLC); and ozuriftabmab vedotin (BA3021), a CAB ADC to treat melanoma and oropharyngeal squamous cell carcinoma. The company is also developing Evalstotug (BA3071), a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for treating melanoma, renal cell carcinoma, colorectal cancer, and NSCLC; BA3182, a bispecific candidate to treat adenocarcinomas; BA3361, a CAB-Nectin-4-ADC for treating tumors; BA3142, a dual-CAB T-cell engager targeting B7-H3, a protein expressed on various solid tumors; and preclinical candidate for CAB-Nectin 4 x CAB-CD3. The company was founded in 2007 and is headquartered in San Diego, California.
OrganisationBioAtla Inc.
Headquarters11085 Torreyana Road, San Diego, CA, United States, 92121
IndustryBiotechnology
CEODr. Jay M. Short Ph.D.
E-voting on sharesClick here to vote

Key Management of BioAtla Inc.

Name

Title

Dr. Eric L. Sievers M.D.

Chief Medical Officer

Ms. Susie Melody

Senior Vice President of Human Resources

Dr. Cathy Chang Ph.D.

Senior Vice President of Research & Development

Dr. Gerhard Frey Ph.D.

Senior Vice President of Technology Development

Ms. Monica Sullivan

Senior Vice President of Intellectual Property & Contracts

Ms. Sheri Lydick

Chief Commercial Officer

Lisa M. Pelton

Accounting Manager

Dr. Jay M. Short Ph.D.

Co-Founder, CEO & Chairman

FAQs

What is BioAtla Inc. share price today?

BioAtla Inc. share price today is $3.68 as on at the close of the market. BioAtla Inc. share today touched a day high of $3.8 and a low of $3.52.

What is the 52 week high and 52 week low for BioAtla Inc. share?

BioAtla Inc. share touched a 52 week high of $71.5 on and a 52 week low of $3.12 on . BioAtla Inc. stock price today i.e. is closed at $3.68,which is 94.85% down from its 52 week high and 17.95% up from its 52 week low.

What is BioAtla Inc.'s market capitalisation today?

BioAtla Inc. market capitalisation is $0.00T as on .

How to invest in BioAtla Inc. Stock (BCAB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for BioAtla Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in BioAtla Inc. Shares that will get you 0.4076 shares as per BioAtla Inc. share price of $3.68 per share as on June 27, 2026 at 8:46 am IST.

What is the minimum amount required to buy BioAtla Inc. Stock (BCAB) from India?

Indian investors can start investing in BioAtla Inc. (BCAB) shares with as little as ₹94.3 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.00 in BioAtla Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on BioAtla Inc. share’s latest price of $3.68 as on June 27, 2026 at 8:46 am IST, you will get 2.7174 shares of BioAtla Inc.. Learn more about fractional shares .

What are the returns that BioAtla Inc. has given to Indian investors in the last 5 years?

BioAtla Inc. stock has given -99.83% share price returns and 27.1% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?